NCT07594340 HAIC vs. TACE Combined With Sintilimab and Bevacizumab for Intermediate HCC (Beyond Up-To-Seven) Status RECRUITING Phase PHASE3
NCT07584317 AI-Based Multimodal Integration for Tumor Microenvironment Analysis and Response Prediction in HCC Treated With TACE Plus Immunotherapy and Targeted Therapy (CHANCE2601) Status NOT_YET_RECRUITING Phase N/A
NCT07580261 YMN-A02 for Advanced Primary Hepatocellular Carcinoma. Status NOT_YET_RECRUITING Phase PHASE1
NCT07558200 Phase Ia/Ib Study of FXB0871 Monotherapy in Locally Advanced/Metastatic Solid Tumors Status NOT_YET_RECRUITING Phase PHASE1
NCT07556835 Outcomes After Liver and Biliary Resection at a High-Volume Center Status NOT_YET_RECRUITING Phase N/A
NCT07553767 Efficacy and Safety of Pegylated Interferon Alpha-2β in Patients With Hepatitis B-related Hepatocellular Carcinoma After Radical Resection Status NOT_YET_RECRUITING Phase EARLY_PHASE1
NCT07543510 Low-Dose Bevacizumab and Atezolizumab Combined With TACE-HAIC in Unresectable Hepatocellular Carcinoma Status NOT_YET_RECRUITING Phase NA
NCT07522411 Sequential FOLFOX-HAIC-TACE Plus Sintilimab-Bevacizumab Neoadjuvant Therapy Versus Direct Resection in Resectable High-Risk Recurrence Hepatocellular Carcinoma Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT07485114 Association Between Galectin-3 Levels and Outcomes in Patients With Renal Cell Carcinoma, Transitional Cell Carcinoma , Non Small Cell Lung Cancer, and Hepatocellular Carcinoma, Treated With PD-1/PDL-1 Inhibitors Status RECRUITING Phase N/A
NCT07479485 MRG006A Combination Therapy for Advanced Hepatocellular Carcinoma (Phase I/II) Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT07429864 Changes in Bile Acids and Microbiota in Patients With Hepatitis D Treated With Bulvertide Status RECRUITING Phase N/A
NCT07404566 Utility of MicroRNAs for Diagnosing Hepatocellular Carcinoma in Hepatitis C Patients Status COMPLETED Phase N/A
NCT07386639 Sex-Specific Machine Learning Models to Predict Distant Metastasis in Liver Cancer Status COMPLETED Phase N/A
NCT07368023 A Retrospective Study of Safety and Efficacy of Locoregional Therapies Combined With Anti-VEGF/TKIs and Immune Checkpoint Inhibitors for All Comers of Intention-to-treat Patients With Unresectable Hepatocellular Carcinoma Status NOT_YET_RECRUITING Phase N/A
NCT07365839 Cemiplimab +/- Fianlimab Post Y90 Radioembolization in Patients With Hepatocellular Carcinoma Status NOT_YET_RECRUITING Phase PHASE1
NCT07356037 Nanocrystalline Megestrol Acetate for Cachectic Stage Locally Advanced Hepatocellular Carcinoma Status NOT_YET_RECRUITING Phase PHASE3